Go back

MRC molecular lab extends collaboration with AstraZeneca

Image: diamond geezer [CC BY-NC-ND 2.0], via Flickr

Funder announces additional $4 million to enable further research between organisations

The Medical Research Council’s Laboratory of Molecular Biology has announced an additional $4 million (£3.2m) in funding to extend its collaboration with the pharmaceutical giant AstraZeneca.

The Blue Sky collaboration, dating back to 2014, supports pre-clinical research projects that encourage ‘blue-sky’ thinking around fundamental biology and disease.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.